Core Viewpoint - The incidence of cervical cancer in China is rising and becoming more prevalent among younger women, posing a significant threat to their health. Vaccination against HPV is highlighted as an effective preventive measure against high-risk HPV infections and cervical cancer [1]. Group 1: HPV Vaccination Initiative - The National Health Commission, in collaboration with the National Administration of Traditional Chinese Medicine and the National Center for Disease Control and Prevention, announced a continuation of public health service projects in 2026, including free HPV vaccinations for girls aged 13 [1]. - Research indicates that girls aged 9-14 who receive the HPV vaccine have antibody levels more than twice that of those aged 15 and older, with protection lasting over 10 years [3]. - The HPV vaccine included in the national immunization program is a bivalent vaccine requiring two doses spaced six months apart, which can effectively prevent over 70% of cervical cancer cases [3].
国家疾控局：9-14周岁女孩接种HPV疫苗后的抗体水平是15周岁以上者的2倍以上
Xin Lang Cai Jing·2026-02-12 09:13